This Government Contract opportunity from Department Of Health And Human Services was posted on May 14, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Cell Line Development and Flow Cytometry Validation
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
This contract involves the development of cell lines expressing G-protein-coupled receptors (GPCRs) as well as corresponding control lines, with a focus on validating the binding specificity of single-domain antibodies (sdAbs) using flow cytometry. The validation process requires that the target proteins be expressed in their native conformations on the cell surface to ensure accurate assessment of sdAb binding. The contract is a subcontract opportunity designated as a total small business set-aside under the NAICS code 541715, indicating it is related to research and development in physical, engineering, and life sciences. Issued by the National Institutes of Health under the Department of Health and Human Services, the work is to be performed in Bethesda, with a deadline for responses set for May 24, 2026. This project supports the precise characterization of antibody binding, which is critical for applications in research and therapeutic development involving GPCR targets. The contract emphasizes adherence to rigorous scientific and procedural standards to ensure reliable and reproducible results in flow cytometry assays.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20817, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
